RPM Manual
The practical 2026 guide to device rules, day thresholds, management time, and audit defensibility for Remote Patient Monitoring.
Read the RPM Guide →Converting CPAs into revenue contracts without creating Stark or Anti Kickback exposure
Compliance note: This resource is educational and not legal advice. Any financial relationship between a pharmacy and a prescriber should be reviewed for compliance with federal and state law, payer contract terms, and the specific facts of your program.
A common operational mistake is treating a Collaborative Practice Agreement (CPA) as if it were a business contract. A CPA is primarily a clinical delegation framework under state law that defines what patient care functions a pharmacist may perform under specified conditions. It is not, by itself, a compensation framework.
If you are performing care management work that supports a physician or other eligible billing practitioner (for example, care management operations that sit behind RPM, CCM, or APCM), you need a separate written services agreement that defines compensation, responsibilities, documentation expectations, and compliance constraints. Many organizations use a Management Services Agreement (MSA) for this purpose.
Key correction: An MSA does not magically “create a safe harbor.” Safe harbors are regulatory constructs under the federal Anti Kickback Statute (AKS). Stark is a separate statute with separate exceptions. What an MSA can do is structure the relationship so it has a chance to fit an applicable AKS safe harbor and, where Stark applies, a Stark exception.
A CPA creates a formal collaborative relationship that can expand pharmacist-delivered patient care functions, such as initiating, modifying, or managing medication therapy under defined protocols, depending on state law.
A CPA typically does not define a payment model, a fee schedule, fair market value methodology, invoicing terms, or the compliance guardrails that make a payments trail defensible during scrutiny.
Why this matters operationally: If you deliver ongoing clinical work and the prescriber bills Medicare for services that your work supports, a CPA alone does not obligate the prescriber to compensate you. Even if the prescriber wants to pay you, paying “after the fact” without a written agreement and a set in advance methodology makes it much harder to defend the arrangement as legitimate services compensation rather than remuneration intended to influence referrals.
An MSA is a written services agreement where one party provides defined operational services to another party for compensation. In a pharmacy to practice relationship, the MSA typically describes how pharmacy staff support the practice’s care management operations, how work is documented, how compliance constraints are handled, and how the pharmacy is paid.
Avoid the “fee splitting” trap: Whether something is illegal fee splitting depends heavily on state law and the structure of the arrangement. The safe posture is to pay for services rendered at fair market value, not to share a percentage of collections.
The AKS safe harbor (42 CFR 1001.952(d)) requires:
The Stark exception (42 CFR 411.357(d)) requires:
Meeting a safe harbor is voluntary. Failing to meet a safe harbor does not automatically mean an arrangement is illegal; it means you fall into a facts and circumstances analysis zone.
Compensation must be consistent with FMV in arm’s-length transactions. Avoid percentage of collections or "splitting Medicare reimbursements," as these vary with the value of business generated.
The methodology must be set in advance. You cannot “true up” because reimbursement was high this month. The agreement must define the calculation before services begin.
Both frameworks prohibit taking into account the volume or value of referrals. Do not tie discounts or fees to where prescriptions are filled.
Clinical Authorization
Defines what clinical functions are delegated, under what protocols, and with what oversight under state law. Answers: What clinical work can the pharmacist do?
Financial & Operational Authorization
Defines services, deliverables, compensation methodology, and compliance constraints. Answers: What services is the pharmacy providing and how is it paid?
Fee is pegged to reimbursement, collections, or code value.
Fees change month to month based on what Medicare paid.
Fees drop if the practice agrees to send prescriptions to the pharmacy.
“Consulting” payments with no defined deliverables.
Services that are really marketing or patient steering.
No written agreement, expired agreement, or work outside scope.
While most platforms simply record what happened, FairPath actively runs the program. It continuously monitors every patient, staff action, and billing rule across CCM, RPM, RTM, and APCM, intervening immediately when a requirement is missed.
This allows you to scale your own program without losing quality, breaking trust with physicians, or losing control of your revenue. We provide the precision of an automated medical director without the chaos.
FairPath is built on operational work, not theory. We publish the playbooks and checklists we use to keep programs compliant and profitable. Use them whether you run FairPath or not.
Browse the Expert Library →The practical 2026 guide to device rules, day thresholds, management time, and audit defensibility for Remote Patient Monitoring.
Read the RPM Guide →How to run Remote Therapeutic Monitoring for MSK, respiratory, and CBT workflows with the correct 9897x and 9898x rules.
Read the RTM Guide →Calendar-month operations for CCM: consent, initiating visit, care plan requirements, time counting, and concurrency rules.
Read the CCM Guide →The operator blueprint for Advanced Primary Care Management: eligibility, G0556–G0558 tiers, and monthly execution.
Read the APCM Playbook →